|
1
|
Shaw D: Toxicological risks of Chinese
herbs. Planta Med. 76:2012–2018. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wu XY, Tang JL, Mao C, Yuan JQ, Qin Y and
Chung VC: Systematic reviews and meta-analyses of traditional
chinese medicine must search chinese databases to reduce language
bias. Evid Based Complement Alternat Med. 2013:8121792013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Leung AY: Traditional toxicity
documentation of Chinese Materia Medica-an overview. Toxicol
Pathol. 34:319–326. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang JX and Wang XM: Progress in studies
on anti-hepatoma effect of traditional Chinese medicine by
adjusting immune function. Zhongguo Zhong Yao Za Zhi. 32:281–284.
2007.(In Chinese). PubMed/NCBI
|
|
5
|
Yang D and Tian G: Review of experimental
study on treatment of lung cancer with traditional Chinese
medicine. Zhongguo Zhong Yao Za Zhi. 34:2405–2409. 2009.(In
Chinese). PubMed/NCBI
|
|
6
|
Li YJ, Zhao X, Vecchiarelli-Federico LM,
Li Y, Datti A, Cheng Y and Ben-David Y: Drug-mediated inhibition of
Fli-1 for the treatment of leukemia. Blood Cancer J. 2:e542012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li YJ, Liu G, Xia L, Xiao X, Liu JC,
Menezes ME, Das SK, Emdad L, Sarkar D, Fisher PB, et al:
Suppression of Her2/Neu mammary tumor development in mda-7/IL-24
transgenic mice. Oncotarget. 6:36943–36954. 2015.PubMed/NCBI
|
|
8
|
Usenko T, Li YJ, Haeri M, Li Y,
Vecchiarelli-Federico LM, Zhao X, Prchal JT and Ben-David Y:
Enrichment of Sca1+ hematopoietic progenitors in polycythemic mice
inhibits leukemogenesis. Blood. 114:1831–1841. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Livak KJ and Schmittgen TD: Analysis of
Relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. METHODS. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hermawan A, Wagner E and Roidl A:
Consecutive salinomycin treatment reduces doxorubicin resistance of
breast tumor cells by diminishing drug efflux pump expression and
activity. Oncol Rep. 35:1732–1740. 2016.PubMed/NCBI
|
|
11
|
Yu X, Yang L, Cairns MJ, Dass C, Saravolac
E, Li X and Sun LQ: Chemosensitization of solid tumors by
inhibition of Bcl-xL expression using DNAzyme. Oncotarget.
5:9039–9048. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lu SJ, Man S, Bani MR, Adachi D, Hawley
RG, Kerbel RS and Ben-David Y: Retroviral insertional mutagenesis
as a strategy for the identification of genes associated with
cis-diamminedichloroplatinum(II) resistance. Cancer Res.
55:1139–1145. 1995.PubMed/NCBI
|
|
13
|
Pastorek M, Gronesova P, Cholujova D,
Hunakova L, Bujnakova Z, Balaz P, Duraj J, Lee TC and Sedlak J:
Realgar (As4S4) nanoparticles and arsenic trioxide (As2O3) induced
autophagy and apoptosis in human melanoma cells in vitro.
Neoplasma. 61:700–709. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen J, Li L, Su J, Li B, Chen T and Wong
YS: Synergistic apoptosis-inducing effects on A375 human melanoma
cells of natural borneol and curcumin. PLoS One. 9:e1012772014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lu Y, Chen X, Du S, Wu Q, Yao Z and Zhai
Y: The in situ and in vivo study on enhancing effect of borneol in
nasal absorption of Geniposide in rats. Arch Pharm Res. 33:691–696.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li Y, Luo H, Liu T, Zacksenhaus E and
Ben-David Y: The ets transcription factor Fli-1 in development,
cancer and disease. Oncotarget. 34:2022–2031. 2015.
|
|
17
|
Ben-David Y, Giddens EB, Letwin K and
Bernstein A: Erythroleukemia induction by Friend murine leukemia
virus: Insertional activation of a new member of the ets gene
family, Fli-1, closely linked to c-ets-1. Genes Dev. 5:908–918.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee CR, Cervi D, Truong AH, Li YJ, Sarkar
A and Ben-David Y: Friend virus-induced erythroleukemias: A unique
and well-defined mouse model for the development of leukemia.
Anticancer Res. 23:2159–2166. 2003.PubMed/NCBI
|
|
19
|
Athanasiou M, Mavrothalassitis G,
Sun-Hoffman L and Blair DG: FLI-1 is a suppressor of erythroid
differentiation in human hematopoietic cells. Leukemia. 14:439–445.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zochodne B, Truong AH, Stetler K, Higgins
RR, Howard J, Dumont D, Berger SA and Ben-David Y: Epo regulates
erythroid proliferation and differentiation through distinct
signaling pathways: Implication for erythropoiesis and Friend
virus-induced erythroleukemia. Oncogene. 19:2296–2304. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lakhanpal GK, Vecchiarelli-Federico LM, Li
YJ, Cui JW, Bailey ML, Spaner DE, Dumont DJ, Barber DL and
Ben-David Y: The inositol phosphatase SHIP-1 is negatively
regulated by Fli-1 and its loss accelerates leukemogenesis. Blood.
116:428–436. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ben-David Y, Giddens EB and Bernstein A:
Identification and mapping of a common proviral integration site
Fli-1 in erythroleukemia cells induced by Friend murine leukemia
virus. Proc Natl Acad Sci USA. 87:1332–1336. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Emi M, Kim R, Tanabe K, Uchida Y and Toge
T: Targeted therapy against Bcl-2-related proteins in breast cancer
cells. Breast Cancer Res. 7:R940–952. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nold MF, Mangan NE, Rudloff I, Cho SX,
Shariatian N, Samarasinghe TD, Skuza EM, Pedersen J, Veldman A,
Berger PJ and Nold-Petry CA: Interleukin-1 receptor antagonist
prevents murine bronchopulmonary dysplasia induced by perinatal
inflammation and hyperoxia. Proc Natl Acad Sci USA.
110:14384–14389. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gabrilovich DI and Nagaraj S:
Myeloid-derived suppressor cells as regulators of the immune
system. Nat Rev Immunol. 9:162–174. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Meyer C, Sevko A, Ramacher M, Bazhin AV,
Falk CS, Osen W, Borrello I, Kato M, Schadendorf D, Baniyash M and
Umansky V: Chronic inflammation promotes myeloid-derived suppressor
cell activation blocking antitumor immunity in transgenic mouse
melanoma model. Proc Natl Acad Sci USA. 108:17111–17116. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang F, Lu Y, Liu J and Shi J: Realgar is
active ingredient of Angong Niuhuang pill in protection against
LPS-induced neuroinflammation. Zhongguo Zhong Yao Za Zhi.
35:3333–3338. 2010.(In Chinese). PubMed/NCBI
|
|
28
|
Zhang F, Lu Y, Wu Q, Yan J, Shi J and Liu
J: Role of cinnabar and realgar of WSHFD in protecting against
LPS-induced neurotoxicity. J Ethnopharmacol. 139:822–828. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhong W, Cui Y, Yu Q, Xie X, Liu Y, Wei M,
Ci X and Peng L: Modulation of LPS-stimulated pulmonary
inflammation by Borneol in murine acute lung injury model.
Inflammation. 37:1148–1157. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cui JW, Vecchiarelli-Federico LM, Li YJ,
Wang GJ and Ben-David Y: Continuous Fli-1 expression plays an
essential role in the proliferation and survival of F-MuLV-induced
erythroleukemia and human erythroleukemia. Leukemia. 23:1311–1319.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cervi D, Klement G, Stempak D, Baruchel S,
Koki A and Ben-David Y: Targeting cyclooxygenase-2 reduces overt
toxicity toward low-dose vinblastine and extends survival of
juvenile mice with Friend disease. Clin Cancer Res. 11:712–719.
2005.PubMed/NCBI
|
|
32
|
Motallebnezhad M, Jadidi-Niaragh F,
Qamsari ES, Bagheri S, Gharibi T and Yousefi M: The immunobiology
of myeloid-derived suppressor cells in cancer. Tumour Biol.
37:1387–1406. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Parker KH, Beury DW and Ostrand-Rosenberg
S: Myeloid-derived suppressor cells: Critical cells driving immune
suppression in the tumor microenvironment. Adv Cancer Res.
128:95–139. 2015. View Article : Google Scholar : PubMed/NCBI
|
